For example, STAT3 was a treatment target for bladder cancer therapy, and the anti-bladder cancer effects of berberine might involve disturbing the AK2-STAT3 signaling pathway via upregulation of miR-17-5p [19]. This evidence concerns the gene STAT3 and urinary bladder carcinoma.